A randomized controlled study of acupuncture in the treatment of diarrhea-predominant irritable bowel syndrome

Beijing University of Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•(1) Persons aged 18-70 years old, regardless of gender;
•(2) Those who meet the above diagnostic criteria of IBS-D Rome IV; have typical symptoms of IBS-D;
•(3) The course of the disease exceeds 6 months;
•(4) The total score of the IBS Severity Scale at the baseline period is =75 points;
•(5) Patients with mild or moderate depression or anxiety, that is, those with a GAD-7 total score of 5-15, or a PHQ-9 total score of 5-15;
•(6) Normal cognitive function, good compliance, willing to cooperate with the research, voluntarily participate in this trial and sign the informed consent.
•Note: Inclusion only if all the above conditions are met.

•(1) Those who meet the diagnostic criteria of IBS-C, IBS-M, and IBS-U Rome IV;
•(2) Those who have been diagnosed with organic diseases of the digestive system in the past, such as inflammatory bowel disease, intestinal tuberculosis, intestinal tumors, etc.;
•(3) Patients with severe heart, cerebrovascular system, liver, kidney, hematopoietic system, endocrine system, and rheumatic immune system in the past;
•(4) Severe mental illness and obvious cognitive impairment in the past;
•(5) Patients who have received acupuncture treatment in the past three months;
•(6) Pregnant or lactating women;
•(7) Patients who are participating in other clinical studies.
•Note: All patients who meet any one of the above items will be excluded.

发起方

Beijing University of Chinese Medicine